Article: NitroMed Reports Financial Results for First Quarter 2006; Conference Call and Webcast to be Held Today at 9:00 AM ET.

LEXINGTON, Mass. -- NitroMed, Inc. (NASDAQ: NTMD) today reported financial results for the first quarter ended March 31, 2006.

Total revenue for the three months ended March 31, 2006 was $2.3 million compared to $0.4 million for the same period in 2005, an increase of $1.9 million. Product sales of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) accounted for all of the Company's revenue during the first quarter of 2006, and license fees accounted for all of the Company's revenue during the first quarter of 2005.

Total operating expenses for the three months ended March 31, 2006, excluding cost of product sales of $0.9 million, were $27.8 ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!